Pgdip cancer and therapeutics barts cancer institute

Overview
Your browser does not support iframes
This programme aims to provide students with a clear understanding of the molecular and cellular biology fundamental to cancer biology and cancer research.
Students will learn how research in this area has advanced the treatment and diagnoses of cancer, and gain knowledge of how new therapies are developed, evaluated and implemented.
This will be underpinned by a thorough knowledge of research methodologies and laboratory techniques.
This programme will:
Give you a thorough grounding in the principles underlying cancer treatment
Introduce you to the regulatory framework underlying clinical research
Show you the steps involved in developing and implementing new treatments and how to apply this knowledge in your professional role
Encourage you to contribute to the research activity and knowledge base in improving cancer care.
Why study your PGDip at Queen Mary University of London?
Barts and the London School of Medicine and Dentistry is comprised of two world renowned teaching hospitals, St Bartholomew's and The Royal London. Both continue to make an outstanding contribution to modern medicine and together have been consistently ranked among the top five in the UK for medicine.
Barts Cancer Institute (BCI) is a Cancer Research-UK Centre of Excellence and a leading cancer research institute in the UK.
This course provides a solid background to cancer therapy, but then allows you to specialise in areas you are interested in following
This course is available via distance learning as well as classroom teaching
We have world leading expertise in several cancer therapies and one of the strongest cancer prevention units in Europe
This programme provides comprehensive training in research methods
Study and contribute to the latest developments in curing cancer, such as novel drugs and gene therapy
Facilities for distance learners